Chemed (NYSE:CHE) CEO Kevin Mcnamara Sells 2,000 Shares of Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the transaction, the chief executive officer directly owned 70,418 shares in the company, valued at approximately $37,991,215.18. This represents a 2.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Chemed Trading Down 0.8%

CHE traded down $4.55 during trading on Tuesday, reaching $536.02. The company had a trading volume of 23,015 shares, compared to its average volume of 221,367. The stock has a market cap of $7.11 billion, a P/E ratio of 26.98, a PEG ratio of 2.02 and a beta of 0.51. The business has a 50 day simple moving average of $469.13 and a 200-day simple moving average of $437.15. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $551.68. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same quarter in the previous year, the business posted $4.27 earnings per share. The business’s revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities analysts anticipate that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.4%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio is presently 12.05%.

Institutional Trading of Chemed

Several institutional investors and hedge funds have recently modified their holdings of the stock. Geneos Wealth Management Inc. raised its position in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of Chemed by 67.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after buying an additional 4,560 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of Chemed in the 2nd quarter valued at about $579,000. Brown Advisory Inc. boosted its holdings in shares of Chemed by 36.9% in the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after buying an additional 148 shares in the last quarter. Finally, Cerity Partners LLC raised its stake in shares of Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after acquiring an additional 3,133 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Oppenheimer raised their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Royal Bank Of Canada increased their target price on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Chemed presently has a consensus rating of “Hold” and a consensus price target of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.